ResearcherUniversity of SzegedActive in the last 2 years
Zoltán Veréb
Matched on ORCID iD 0000-0002-9518-2155; OpenAlex author ID A5001861724. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 5
- MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. Co-author DOI 10.1159/000541874↗
- Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes. Last author DOI 10.3390/ijms26010390↗
- Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach. Co-author DOI 10.1016/j.jbiotec.2024.05.010↗
- Importance of MUC17 in the bile-induced pancreatic cancer progression Co-author DOI 10.1016/j.pan.2023.06.769↗
- Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. First author DOI 10.1038/s41598-020-79181-6↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Viktória Venglovecz · 5 shared papers, 2020–2025 · strength 0.99
- Paper Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes. DOI 10.3390/ijms26010390↗
- Paper Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing… DOI 10.1016/j.jbiotec.2024.05.010↗
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874↗
- Eleonóra Gál · 4 shared papers, 2020–2025 · strength 0.75
- Paper Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing… DOI 10.1016/j.jbiotec.2024.05.010↗
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874↗
- Paper Importance of MUC17 in the bile-induced pancreatic cancer progression DOI 10.1016/j.pan.2023.06.769↗
- László Czakó · 3 shared papers, 2020–2025 · strength 0.51
- Paper MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. DOI 10.1159/000541874↗
- Paper Importance of MUC17 in the bile-induced pancreatic cancer progression DOI 10.1016/j.pan.2023.06.769↗
- Paper Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. DOI 10.1038/s41598-020-79181-6↗
- Shahram Parvaneh · 2 shared papers, 2024–2025 · strength 0.49
- Paper Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes. DOI 10.3390/ijms26010390↗
- Paper Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing… DOI 10.1016/j.jbiotec.2024.05.010↗
- Péter Jenő Hegyi · 2 shared papers, 2020–2024 · strength 0.35
- Paper Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing… DOI 10.1016/j.jbiotec.2024.05.010↗
- Paper Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. DOI 10.1038/s41598-020-79181-6↗
- Boshra Yosef · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.